Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Bettina Kemkes-Matthes"'
Autor:
Barbara Preisler, Behnaz Pezeshkpoor, Atanas Banchev, Ronald Fischer, Barbara Zieger, Ute Scholz, Heiko Rühl, Bettina Kemkes-Matthes, Ursula Schmitt, Antje Redlich, Sule Unal, Hans-Jürgen Laws, Martin Olivieri, Johannes Oldenburg, Anna Pavlova
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 2, p 347 (2021)
Background: Familial multiple coagulation factor deficiencies (FMCFDs) are a group of inherited hemostatic disorders with the simultaneous reduction of plasma activity of at least two coagulation factors. As consequence, the type and severity of symp
Externí odkaz:
https://doaj.org/article/39e96b8d434f4c029c4e6744cf87bf3d
Autor:
Anette Kirsch-Altena, Beate Luxembourg, Ulrich J. Sachs, Bettina Kemkes-Matthes, Franziska Henke
Publikováno v:
Thrombosis Research. 200:121-127
Introduction Because of the rarity of double heterozygosity for Factor V Leiden (FVL) and Prothrombin (FII) G20210A, little is known about the thrombotic phenotype in double heterozygotes. Material and methods In a retrospective cohort study of patie
Autor:
Ulrich J. Sachs, Benjamin Franke, Beate Luxembourg, Bettina Kemkes-Matthes, Kathrin Heidinger
Publikováno v:
Blood Coagulation & Fibrinolysis. 33:184-187
The current mainstay for the treatment of thrombotic antiphospholipid syndrome (APS) is anticoagulation with vitamin K antagonists (VKAs). The use of direct oral anticoagulants (DOACs) is under debate. We aimed to assess whether DOACs would be safe i
Autor:
Bettina Kemkes-Matthes, Ingrid M. Bistervels, WE Paulus, Sandra Marten, Martin Bornhäuser, Luise Tittl, Saskia Middeldorp, Jan Beyer-Westendorf, Christof Schaefer, Will Thomas
Publikováno v:
Lancet. Haematology, 7(12), e884-e891. Lancet Publishing Group
Summary Background Direct oral anticoagulants (DOACs) have largely replaced vitamin K antagonists in many indications for anticoagulation. Prescribed to millions of patients, including women of reproductive age, exposure to DOACs in early pregnancy i
Publikováno v:
Hämostaseologie. 42:274-275
Autor:
Bettina Kemkes-Matthes, Heiko Rühl, Atanas Banchev, Ursula Schmitt, Martin Olivieri, Ronald Fischer, Hans-Jürgen Laws, Sule Unal, Barbara Zieger, Barbara Preisler, Johannes Oldenburg, Ute Scholz, Anna Pavlova, Behnaz Pezeshkpoor, Antje Redlich
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 347, p 347 (2021)
Journal of Clinical Medicine
Volume 10
Issue 2
Journal of Clinical Medicine
Volume 10
Issue 2
Background: Familial multiple coagulation factor deficiencies (FMCFDs) are a group of inherited hemostatic disorders with the simultaneous reduction of plasma activity of at least two coagulation factors. As consequence, the type and severity of symp
Autor:
Schmitt Ursula, Ute Scholz, Anna Pavlova, Bettina Kemkes-Matthes, Eberl Wolfgang, B. Zieger, Behnaz Pezeshkpoor, Martin Olivieri, Anja Moldenhauer, Krause Michael
Publikováno v:
Hamburger Hämophilie Symposion Hamburg, Germany.
Publikováno v:
Journal of thrombosis and haemostasis : JTHReferences. 19(3)
Emicizumab is currently approved to prevent bleeding in patients with congenital hemophilia A with or without neutralizing antibodies (inhibitors) against factor VIII (FVIII). Here, we present a case-based discussion of its potential use in acquired
Autor:
Markus M. Lerch, Hendrik Lehnert, Sebastian M. Schellong, Ludwig Sacha Weilemann, Michael P. Manns, Michael Hallek, Walter Swoboda, Andreas Neubauer, Gerd Hasenfuß, Elisabeth Märker-Hermann, Jan Rupp, Joachim Mössner, J. Floege, Tobias Welte, Bettina Kemkes-Matthes, Cornel C. Sieber
Publikováno v:
Springer Reference Medizin ISBN: 9783642546761
SpringerReference Innere Medizin
SpringerReference Innere Medizin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6e6d7849d10513480fdd471751fb4eb
https://doi.org/10.1007/978-3-642-54676-1
https://doi.org/10.1007/978-3-642-54676-1
Publikováno v:
Science meets clinical practice.